Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Nimbidin is a major active compound isolated from the seeds of the neem tree (Azadirachta indica). Its use for eczema is primarily supported by scientific investigations, although the evidence remains limited and largely preclinical. Several studies have demonstrated that nimbidin possesses notable anti-inflammatory, antibacterial, and immunomodulatory properties. For example, research published in the journal Phytotherapy Research (1984) showed that nimbidin can suppress inflammation in animal models such as rats and mice. Additionally, a study in Indian Journal of Pharmacology (1994) reported that nimbidin reduced contact dermatitis symptoms in guinea pigs, an experimental model for eczema.

These effects are attributed to nimbidin’s ability to inhibit the release of histamine and other mediators involved in skin inflammation. Furthermore, neem extracts (containing nimbidin) have been used in traditional medicine for various skin ailments, including eczema, but direct clinical trials in humans evaluating purified nimbidin for eczema are lacking. As a result, while there is promising preclinical and mechanistic evidence, robust clinical validation is insufficient. Thus, nimbidin’s use in eczema is scientifically plausible but not yet strongly supported by high-quality human studies.

In summary, nimbidin is supported by limited scientific evidence (rated 2/5) for eczema, primarily based on animal studies and mechanistic data, but lacks direct clinical trial confirmation in humans.

More about Nimbidin
More about Eczema

Other ingredients used for Eczema

Other health conditions supported by Nimbidin

Products containing Nimbidin